Sample Name
Sample Code
Sample Name
Sample Code
Sample Name
Sample Code
4
ProShares Ultra Energy
DIG
5
United States Gasoline Fund Lp
UGA
US Stock MarketDetailed Quotes
Regentis Biomaterials (RGNT)
- 2.040
- +0.070+3.55%
Close Sep 8 16:00 ET
- 2.000
- -0.040-1.96%
Post 19:52 ET
14.33MMarket Cap-0.77P/E (TTM)
2.040High1.920Low57.48KVolume2.000Open1.970Prev Close115.10KTurnover4.60%Turnover RatioLossP/E (Static)7.02MShares15.50052wk High3.02P/B2.55MFloat Cap1.23252wk Low--Dividend TTM1.25MShs Float15.500Highest--Div Yield TTM6.09%Range %1.232Lowest2.002Avg Price1Lot Size
Regentis Biomaterials (RGNT) News
All
Earnings
Transactions
Shareholding
Events
Other
Regentis Biomaterials | SCHEDULE 13G: Others
Regentis Biomaterials | S-8: Initial registration statement for securities to be offered to employees pursuant to employee benefit plans
Regentis Biomaterials | 6-K: Report of foreign private issuer [Rules 13a-16 and 15d-16]
Regentis Biomaterials | 6-K: Report of foreign private issuer [Rules 13a-16 and 15d-16]
Regentis Biomaterials | EFFECT: Others
Regentis Biomaterials | 4: Statement of changes in beneficial ownership of securities-Director Alpert Susan PHD MD
Regentis Biomaterials | 424B3: Prospectus
Regentis Biomaterials | 4: Statement of changes in beneficial ownership of securities-Director Ben-Elazar Pini
Regentis Biomaterials | 4: Statement of changes in beneficial ownership of securities-Director Valentine Keith
Regentis Biomaterials | 4: Statement of changes in beneficial ownership of securities-Director Dykan Jeff
Regentis Biomaterials | 4: Statement of changes in beneficial ownership of securities-Officer GELLER EHUD
Regentis Biomaterials | 4: Statement of changes in beneficial ownership of securities-Director Cohen-Arazi Efraim
Regentis Biomaterials | 6-K: Report of foreign private issuer [Rules 13a-16 and 15d-16]
Regentis Biomaterials | F-1: Registration statement for securities of certain foreign private issuers
Regentis Biomaterials | 6-K: Report of foreign private issuer [Rules 13a-16 and 15d-16]
Regentis Biomaterials | D: Filing D
6-K: Regentis Biomaterials | 6-K: Report of foreign private issuer (related to financial reporting)
Regentis Biomaterials | 6-K: Report of foreign private issuer [Rules 13a-16 and 15d-16]
Regentis Biomaterials | RW: Registration Withdrawal Request
Regentis Biomaterials | F-1/A: Registration statement for securities of certain Canadian issuers (Amendment)
Market Insights
China Concept Stocks China Concept Stocks
Chinese Concept Stocks refer to companies with core operations and revenue from Mainland China, listed on U.S. exchanges. They serve as a key bridge for global investors to access China's growth and innovation. Chinese Concept Stocks refer to companies with core operations and revenue from Mainland China, listed on U.S. exchanges. They serve as a key bridge for global investors to access China's growth and innovation.
View More
Hot Topics Hot Topics
Middle East conflict spreads to the stock market! How should investors respond?
On September 1, U.S. Eastern Time, the U.S. military launched a new round of strikes against Iran in response to recent attempts by the Isla
牛牛課堂
Mar 4 17:09
Long-term answers | Your account on the left shrinks, while your right hand is chased by the times — Be the person that no bombardment can ever wipe out.
牛牛課堂
Mar 18 18:18
Hormuz, Term Structure and USO: Navigating the Energy Storm